On April 28, 2015, Ninox Medical Ltd. closed the transaction. The series B round was led by Vesalius Biocapital Partners S.à r.l., and new investors, Pitango Venture Capital and Mérieux Participations 2, SAS, a fund managed by Mérieux Equity Partners SAS. The company has received $12.50 million in funding till date.

As part of the round, Dr. David Israeli of Pitango Venture Capital and Valérie Calenda of Mérieux Equity Partners SAS has joined the company's board of directors.